Trial intelligence / Profile preview

Procrit Versus Placebo in Pre-Operative Patients Undergoing Major Surgical Oncology Operations

NCT00624312Phase 2Withdrawn

Sponsor
University of Louisville
Start
Feb 2008
Primary completion
Jan 2010
Modality
Biologic, rProtein (Recombinant Protein)
Countries
1
01

Overview

A Phase 2 trial of epoetin alfa in anemia, sponsored by University of Louisville. Planned start Feb 2008; status: withdrawn.

02

Drugs

epoetin alfa
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00624312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00624312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call